{"data":[{"accessionNo":"0000905148-26-002430","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001796280","issuerName":"Oric Pharmaceuticals, Inc.","ticker":"ORIC","cusip":"68622P109","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"HALVORSEN OLE ANDREAS","reportingCik":null,"personType":"IN","sharesOwned":8264607,"percentOfClass":7.8,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0000905148-26-002430","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001796280","issuerName":"Oric Pharmaceuticals, Inc.","ticker":"ORIC","cusip":"68622P109","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"VIKING GLOBAL INVESTORS LP","reportingCik":null,"personType":"PN","sharesOwned":8264607,"percentOfClass":7.8,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0000905148-26-002430","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001796280","issuerName":"Oric Pharmaceuticals, Inc.","ticker":"ORIC","cusip":"68622P109","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Viking Global Opportunities Parent GP LLC","reportingCik":null,"personType":"OO","sharesOwned":8264607,"percentOfClass":7.8,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0000905148-26-002430","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001796280","issuerName":"Oric Pharmaceuticals, Inc.","ticker":"ORIC","cusip":"68622P109","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Shabet Rose Sharon","reportingCik":null,"personType":"IN","sharesOwned":8264607,"percentOfClass":7.8,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0000080255-26-000420","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001796280","issuerName":"ORIC PHARMACEUTICALS INC","ticker":"ORIC","cusip":"68622P109","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"T. Rowe Price Associates, Inc.","reportingCik":null,"personType":"IA","sharesOwned":5387783,"percentOfClass":5.4,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0000905148-26-002430","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001796280","issuerName":"Oric Pharmaceuticals, Inc.","ticker":"ORIC","cusip":"68622P109","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Viking Global Opportunities Portfolio GP LLC","reportingCik":null,"personType":"OO","sharesOwned":5250103,"percentOfClass":5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0000905148-26-002430","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001796280","issuerName":"Oric Pharmaceuticals, Inc.","ticker":"ORIC","cusip":"68622P109","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Viking Global Opportunities Illiquid Investments Sub-Master LP","reportingCik":null,"personType":"PN","sharesOwned":5250103,"percentOfClass":5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0000905148-26-002430","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001796280","issuerName":"Oric Pharmaceuticals, Inc.","ticker":"ORIC","cusip":"68622P109","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Viking Global Opportunities GP LLC","reportingCik":null,"personType":"OO","sharesOwned":5250103,"percentOfClass":5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0001738048-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001796280","issuerName":"ORIC Pharmaceuticals, Inc.","ticker":"ORIC","cusip":"68622P109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Venrock Healthcare Capital Partners EG, L.P.","reportingCik":null,"personType":"PN","sharesOwned":4319765,"percentOfClass":4.2,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0001738048-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001796280","issuerName":"ORIC Pharmaceuticals, Inc.","ticker":"ORIC","cusip":"68622P109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Venrock Healthcare Capital Partners III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":4319765,"percentOfClass":4.2,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0001738048-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001796280","issuerName":"ORIC Pharmaceuticals, Inc.","ticker":"ORIC","cusip":"68622P109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"VHCP Co-Investment Holdings III, LLC","reportingCik":null,"personType":"OO","sharesOwned":4319765,"percentOfClass":4.2,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0001738048-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001796280","issuerName":"ORIC Pharmaceuticals, Inc.","ticker":"ORIC","cusip":"68622P109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"VHCP Management III, LLC","reportingCik":null,"personType":"OO","sharesOwned":4319765,"percentOfClass":4.2,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0001738048-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001796280","issuerName":"ORIC Pharmaceuticals, Inc.","ticker":"ORIC","cusip":"68622P109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"VHCP Management EG, LLC","reportingCik":null,"personType":"OO","sharesOwned":4319765,"percentOfClass":4.2,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0001738048-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001796280","issuerName":"ORIC Pharmaceuticals, Inc.","ticker":"ORIC","cusip":"68622P109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Nimish Shah","reportingCik":null,"personType":"IN","sharesOwned":4319765,"percentOfClass":4.2,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0001738048-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001796280","issuerName":"ORIC Pharmaceuticals, Inc.","ticker":"ORIC","cusip":"68622P109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Bong Y. Koh","reportingCik":null,"personType":"IN","sharesOwned":4319765,"percentOfClass":4.2,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0000905148-26-002430","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001796280","issuerName":"Oric Pharmaceuticals, Inc.","ticker":"ORIC","cusip":"68622P109","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Viking Global Opportunities Drawdown Portfolio GP LLC","reportingCik":null,"personType":"OO","sharesOwned":3014504,"percentOfClass":2.8,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0000905148-26-002430","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001796280","issuerName":"Oric Pharmaceuticals, Inc.","ticker":"ORIC","cusip":"68622P109","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Viking Global Opportunities Drawdown GP LLC","reportingCik":null,"personType":"OO","sharesOwned":3014504,"percentOfClass":2.8,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0000905148-26-002430","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001796280","issuerName":"Oric Pharmaceuticals, Inc.","ticker":"ORIC","cusip":"68622P109","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Viking Global Opportunities Drawdown (Aggregator) LP","reportingCik":null,"personType":"PN","sharesOwned":3014504,"percentOfClass":2.8,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0000919574-26-003469","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001796280","issuerName":"Oric Pharmaceuticals, Inc.","ticker":"ORIC","cusip":"68622P109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0000919574-26-003469","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001796280","issuerName":"Oric Pharmaceuticals, Inc.","ticker":"ORIC","cusip":"68622P109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0000919574-26-003469","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001796280","issuerName":"Oric Pharmaceuticals, Inc.","ticker":"ORIC","cusip":"68622P109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0001738048-26-000026","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001796280","issuerName":"ORIC Pharmaceuticals, Inc.","ticker":"ORIC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Nimish Shah","reportingCik":null,"personType":"IN","sharesOwned":5676230,"percentOfClass":5.8,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0001738048-26-000026","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001796280","issuerName":"ORIC Pharmaceuticals, Inc.","ticker":"ORIC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Bong Y. Koh","reportingCik":null,"personType":"IN","sharesOwned":5676230,"percentOfClass":5.8,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0001738048-26-000026","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001796280","issuerName":"ORIC Pharmaceuticals, Inc.","ticker":"ORIC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Venrock Healthcare Capital Partners III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":5676230,"percentOfClass":5.8,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0001738048-26-000026","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001796280","issuerName":"ORIC Pharmaceuticals, Inc.","ticker":"ORIC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"VHCP Co-Investment Holdings III, LLC","reportingCik":null,"personType":"OO","sharesOwned":5676230,"percentOfClass":5.8,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0001738048-26-000026","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001796280","issuerName":"ORIC Pharmaceuticals, Inc.","ticker":"ORIC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Venrock Healthcare Capital Partners EG, L.P.","reportingCik":null,"personType":"PN","sharesOwned":5676230,"percentOfClass":5.8,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0001738048-26-000026","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001796280","issuerName":"ORIC Pharmaceuticals, Inc.","ticker":"ORIC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"VHCP Management III, LLC","reportingCik":null,"personType":"OO","sharesOwned":5676230,"percentOfClass":5.8,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0001738048-26-000026","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001796280","issuerName":"ORIC Pharmaceuticals, Inc.","ticker":"ORIC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"VHCP Management EG, LLC","reportingCik":null,"personType":"OO","sharesOwned":5676230,"percentOfClass":5.8,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0002012383-26-000702","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001796280","issuerName":"ORIC PHARMACEUTICALS INC","ticker":"ORIC","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":5473145,"percentOfClass":5.6,"filedAt":"2026-01-21","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0001193125-25-284976","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001796280","issuerName":"ORIC Pharmaceuticals, Inc.","ticker":"ORIC","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"Peter Svennilson","reportingCik":null,"personType":"IN","sharesOwned":3644118,"percentOfClass":3.7,"filedAt":"2025-11-17","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0001193125-25-284976","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001796280","issuerName":"ORIC Pharmaceuticals, Inc.","ticker":"ORIC","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"David V Goeddel","reportingCik":null,"personType":"IN","sharesOwned":3627493,"percentOfClass":3.7,"filedAt":"2025-11-17","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0001193125-25-284976","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001796280","issuerName":"ORIC Pharmaceuticals, Inc.","ticker":"ORIC","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"The Column Group II GP, LP","reportingCik":null,"personType":"PN","sharesOwned":3540777,"percentOfClass":3.6,"filedAt":"2025-11-17","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0001193125-25-284976","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001796280","issuerName":"ORIC Pharmaceuticals, Inc.","ticker":"ORIC","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"The Column Group II, LP","reportingCik":null,"personType":"PN","sharesOwned":3540777,"percentOfClass":3.6,"filedAt":"2025-11-17","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0000902664-25-004920","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001796280","issuerName":"Oric Pharmaceuticals, Inc.","ticker":"ORIC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Alkeon Capital Management LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":4504096,"percentOfClass":4.6,"filedAt":"2025-11-13","canonicalUrl":"https://xoomar.com/markets/stocks/oric"},{"accessionNo":"0000902664-25-004920","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001796280","issuerName":"Oric Pharmaceuticals, Inc.","ticker":"ORIC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Panayotis D. Sparaggis","reportingCik":null,"personType":"HC,IN","sharesOwned":4504096,"percentOfClass":4.6,"filedAt":"2025-11-13","canonicalUrl":"https://xoomar.com/markets/stocks/oric"}],"updatedAt":"2026-11-03T16:40:42.612Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/oric","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}